Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometriosis | 10 | 2023 | 803 | 3.290 |
Why?
|
Pelvic Pain | 3 | 2022 | 248 | 0.910 |
Why?
|
Ovarian Neoplasms | 6 | 2020 | 4748 | 0.900 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 172 | 0.740 |
Why?
|
Mastocytosis, Systemic | 1 | 2021 | 96 | 0.730 |
Why?
|
Contraceptives, Oral | 3 | 2021 | 555 | 0.680 |
Why?
|
Menarche | 2 | 2016 | 492 | 0.620 |
Why?
|
Reproductive History | 2 | 2022 | 208 | 0.600 |
Why?
|
Estrogen Receptor alpha | 2 | 2020 | 578 | 0.590 |
Why?
|
Platinum | 1 | 2016 | 218 | 0.540 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2016 | 236 | 0.520 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 192 | 0.510 |
Why?
|
Hormones | 2 | 2014 | 852 | 0.490 |
Why?
|
Carcinoma, Endometrioid | 1 | 2016 | 286 | 0.480 |
Why?
|
Menopause | 2 | 2016 | 1536 | 0.430 |
Why?
|
Receptors, Progesterone | 1 | 2016 | 1119 | 0.420 |
Why?
|
Ovulation | 2 | 2020 | 182 | 0.370 |
Why?
|
Reproduction | 1 | 2014 | 647 | 0.360 |
Why?
|
Age Factors | 3 | 2021 | 18774 | 0.330 |
Why?
|
Life Style | 2 | 2017 | 3747 | 0.300 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3645 | 0.270 |
Why?
|
Postmenopause | 3 | 2020 | 2423 | 0.250 |
Why?
|
Survival Analysis | 2 | 2017 | 10513 | 0.250 |
Why?
|
Parity | 2 | 2017 | 891 | 0.250 |
Why?
|
Pain | 4 | 2023 | 4692 | 0.230 |
Why?
|
Dyspareunia | 1 | 2022 | 48 | 0.220 |
Why?
|
Survival Rate | 1 | 2016 | 13210 | 0.210 |
Why?
|
Armillaria | 1 | 2020 | 4 | 0.210 |
Why?
|
Ovarian Function Tests | 1 | 2020 | 12 | 0.200 |
Why?
|
Hyphae | 1 | 2020 | 54 | 0.200 |
Why?
|
Menopause, Premature | 1 | 2022 | 124 | 0.200 |
Why?
|
Spores, Fungal | 1 | 2020 | 100 | 0.200 |
Why?
|
Pelvic Floor | 1 | 2021 | 136 | 0.190 |
Why?
|
Women's Health | 2 | 2022 | 1955 | 0.190 |
Why?
|
Female | 24 | 2023 | 377052 | 0.180 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2020 | 183 | 0.180 |
Why?
|
Estrogens | 3 | 2021 | 1529 | 0.180 |
Why?
|
Case-Control Studies | 6 | 2020 | 21802 | 0.170 |
Why?
|
Menstrual Cycle | 2 | 2022 | 533 | 0.170 |
Why?
|
CA-125 Antigen | 1 | 2020 | 279 | 0.170 |
Why?
|
Pain Threshold | 1 | 2021 | 592 | 0.160 |
Why?
|
5-Methylcytosine | 1 | 2017 | 160 | 0.160 |
Why?
|
Comorbidity | 3 | 2023 | 10429 | 0.150 |
Why?
|
Fertility | 1 | 2021 | 726 | 0.150 |
Why?
|
Sterilization, Tubal | 1 | 2016 | 82 | 0.150 |
Why?
|
Adult | 15 | 2022 | 212228 | 0.140 |
Why?
|
Silicon Dioxide | 1 | 2017 | 239 | 0.140 |
Why?
|
Premenopause | 1 | 2020 | 1023 | 0.140 |
Why?
|
Carcinogens | 1 | 2017 | 451 | 0.130 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 573 | 0.130 |
Why?
|
Humans | 26 | 2023 | 715636 | 0.130 |
Why?
|
Abdominal Pain | 1 | 2021 | 1026 | 0.130 |
Why?
|
Biological Evolution | 1 | 2020 | 1083 | 0.130 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 23383 | 0.130 |
Why?
|
Occupational Exposure | 2 | 2017 | 1768 | 0.130 |
Why?
|
Risk Factors | 7 | 2022 | 70927 | 0.130 |
Why?
|
Body Weights and Measures | 1 | 2014 | 216 | 0.120 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2017 | 468 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13620 | 0.120 |
Why?
|
Young Adult | 6 | 2022 | 56137 | 0.120 |
Why?
|
Longevity | 1 | 2020 | 1031 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1308 | 0.110 |
Why?
|
Carcinogens, Environmental | 1 | 2012 | 66 | 0.110 |
Why?
|
Nurses | 1 | 2021 | 2390 | 0.110 |
Why?
|
Ovariectomy | 1 | 2014 | 650 | 0.110 |
Why?
|
Middle Aged | 11 | 2021 | 214618 | 0.110 |
Why?
|
Cohort Studies | 4 | 2022 | 40042 | 0.110 |
Why?
|
Adolescent | 7 | 2022 | 85064 | 0.110 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1336 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1939 | 0.100 |
Why?
|
Ethinyl Estradiol | 2 | 2021 | 118 | 0.100 |
Why?
|
Health Surveys | 2 | 2020 | 4030 | 0.100 |
Why?
|
Incidence | 3 | 2018 | 20761 | 0.100 |
Why?
|
Inhalation Exposure | 1 | 2013 | 436 | 0.100 |
Why?
|
Industry | 1 | 2012 | 366 | 0.090 |
Why?
|
Self Report | 1 | 2021 | 3408 | 0.090 |
Why?
|
Pregnancy | 3 | 2021 | 27366 | 0.090 |
Why?
|
Estrogen Replacement Therapy | 1 | 2016 | 1185 | 0.090 |
Why?
|
Progestins | 2 | 2021 | 283 | 0.090 |
Why?
|
Prospective Studies | 5 | 2021 | 51355 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2013 | 714 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2943 | 0.080 |
Why?
|
Environmental Monitoring | 1 | 2013 | 1372 | 0.080 |
Why?
|
United States | 3 | 2021 | 67894 | 0.070 |
Why?
|
Air Pollution, Indoor | 1 | 2013 | 887 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3427 | 0.060 |
Why?
|
Child | 3 | 2021 | 74418 | 0.060 |
Why?
|
Occupational Diseases | 1 | 2012 | 1459 | 0.060 |
Why?
|
Logistic Models | 2 | 2016 | 13606 | 0.060 |
Why?
|
Scotland | 2 | 2013 | 155 | 0.060 |
Why?
|
Norgestrel | 1 | 2021 | 11 | 0.060 |
Why?
|
Research Design | 1 | 2018 | 5913 | 0.060 |
Why?
|
Desogestrel | 1 | 2021 | 22 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13635 | 0.050 |
Why?
|
Particulate Matter | 1 | 2013 | 2281 | 0.050 |
Why?
|
Dysmenorrhea | 1 | 2022 | 62 | 0.050 |
Why?
|
Levonorgestrel | 1 | 2021 | 73 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11138 | 0.050 |
Why?
|
Mestranol | 1 | 2020 | 9 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 11719 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5191 | 0.050 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2021 | 108 | 0.050 |
Why?
|
Diploidy | 1 | 2020 | 139 | 0.050 |
Why?
|
Time Factors | 3 | 2020 | 40892 | 0.050 |
Why?
|
Air Pollutants | 1 | 2013 | 2634 | 0.050 |
Why?
|
Aged | 5 | 2020 | 162383 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 41184 | 0.040 |
Why?
|
Chromium | 1 | 2017 | 129 | 0.040 |
Why?
|
Neoplasms | 2 | 2017 | 20514 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2021 | 20060 | 0.040 |
Why?
|
Dioxygenases | 1 | 2017 | 313 | 0.040 |
Why?
|
Cytoplasm | 1 | 2020 | 1625 | 0.030 |
Why?
|
Dust | 1 | 2017 | 486 | 0.030 |
Why?
|
Politics | 1 | 2020 | 771 | 0.030 |
Why?
|
Ireland | 1 | 2013 | 161 | 0.030 |
Why?
|
Heating | 1 | 2013 | 90 | 0.030 |
Why?
|
Semiconductors | 1 | 2012 | 101 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2020 | 2993 | 0.030 |
Why?
|
Cooking | 1 | 2013 | 338 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 2014 | 688 | 0.020 |
Why?
|
Laparoscopy | 1 | 2022 | 1980 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3344 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3631 | 0.020 |
Why?
|
Particle Size | 1 | 2013 | 1674 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 14438 | 0.020 |
Why?
|
Seasons | 1 | 2013 | 1437 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 6032 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39334 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8238 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8886 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4642 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 11956 | 0.020 |
Why?
|
DNA Methylation | 1 | 2017 | 4075 | 0.020 |
Why?
|
Health Care Costs | 1 | 2017 | 3165 | 0.020 |
Why?
|
Cost of Illness | 1 | 2013 | 1842 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2012 | 1245 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12546 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8561 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9498 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2023 | 17399 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13219 | 0.010 |
Why?
|
Health Policy | 1 | 2013 | 2650 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10091 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9741 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18185 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 28987 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8042 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 29270 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23482 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2012 | 8801 | 0.010 |
Why?
|
Mice | 1 | 2017 | 80320 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 58288 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2012 | 12530 | 0.010 |
Why?
|
Animals | 1 | 2017 | 169277 | 0.000 |
Why?
|
Male | 1 | 2012 | 350156 | 0.000 |
Why?
|
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_